Bio Co-enzyme Phase

Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (pratensis), Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-ketoglutaricum Acidum, Alpha-lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adrenalinum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur, Aconiticum Acidum, Cis-,

Deseret Biologicals, Inc.
Human Otc Drug
NDC 43742-1661

Bio Co-enzyme Phase also known as Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (pratensis), Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-ketoglutaricum Acidum, Alpha-lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adrenalinum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur, Aconiticum Acidum, Cis-, is a human otc drug labeled by 'Deseret Biologicals, Inc.'. National Drug Code (NDC) number for Bio Co-enzyme Phase is 43742-1661. This drug is available in dosage form of Liquid. The names of the active, medicinal ingredients in Bio Co-enzyme Phase drug includes Acetic Acid - 16 [hp_X]/mL Adenosine Triphosphate Disodium - 10 [hp_X]/mL Alpha Lipoic Acid - 8 [hp_X]/mL Anhydrous Citric Acid - 8 [hp_X]/mL Ascorbic Acid - 6 [hp_X]/mL Barium Oxalosuccinate - 34 [hp_C]/mL Beta Vulgaris Whole - 4 [hp_X]/mL Calcium Sulfide - 10 [hp_X]/mL Cerous Oxalate Nonahydrate - 8 [hp_X]/mL Cysteine - 6 [hp_X]/mL and more. The currest status of Bio Co-enzyme Phase drug is Active.

Drug Information:

Drug NDC:	43742-1661
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Bio Co-enzyme Phase
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Beta Vulgaris, Ascorbicum Acidum, Cysteinum, Natrum Oxalaceticum, Nicotinamidum, Pulsatilla (pratensis), Pyridoxinum Hydrochloricum, Riboflavinum, Thiaminum Hydrochloricum, Alpha-ketoglutaricum Acidum, Alpha-lipoicum Acidum, Cerium Oxalicum, Citricum Acidum, Fumaricum Acidum, Magnesium Oroticum Dihydricum, Malicum Acidum, Nadidum, Natrum Pyruvicum, Pantothenic Acid, Succinicum Acidum, Adrenalinum, Adenosinum Triphosphoricum Dinatrum, Hepar Sulphuris Calcareum, Sulphur, Aconiticum Acidum, Cis-,
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Deseret Biologicals, Inc.
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Liquid
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	ACETIC ACID - 16 [hp_X]/mL ADENOSINE TRIPHOSPHATE DISODIUM - 10 [hp_X]/mL ALPHA LIPOIC ACID - 8 [hp_X]/mL ANHYDROUS CITRIC ACID - 8 [hp_X]/mL ASCORBIC ACID - 6 [hp_X]/mL BARIUM OXALOSUCCINATE - 34 [hp_C]/mL BETA VULGARIS WHOLE - 4 [hp_X]/mL CALCIUM SULFIDE - 10 [hp_X]/mL CEROUS OXALATE NONAHYDRATE - 8 [hp_X]/mL CYSTEINE - 6 [hp_X]/mL Load more... EPINEPHRINE - 8 [hp_X]/mL FUMARIC ACID - 8 [hp_X]/mL MAGNESIUM OROTATE DIHYDRATE - 8 [hp_X]/mL MALIC ACID - 8 [hp_X]/mL MANGANESE PHOSPHATE, DIBASIC - 16 [hp_X]/mL NADIDE - 8 [hp_X]/mL NIACINAMIDE - 6 [hp_X]/mL OXOGLURIC ACID - 8 [hp_X]/mL PANTOTHENIC ACID - 8 [hp_X]/mL PROTEUS MORGANII - 30 [hp_C]/mL PULSATILLA PRATENSIS WHOLE - 6 [hp_X]/mL PYRIDOXINE HYDROCHLORIDE - 6 [hp_X]/mL RIBOFLAVIN - 6 [hp_X]/mL SODIUM DIETHYL OXALACETATE - 6 [hp_X]/mL SODIUM PYRUVATE - 8 [hp_X]/mL SUCCINIC ACID - 8 [hp_X]/mL SULFUR - 10 [hp_X]/mL THIAMINE HYDROCHLORIDE - 6 [hp_X]/mL
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	08 Jun, 2020
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	15 Oct, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	09 May, 2026
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Deseret Biologicals, Inc.
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
NUI:	N0000175833 N0000175835 N0000175980 N0000008556 N0000175089 N0000193618 M0001797 N0000000209 N0000000245 N0000175552 N0000175555 N0000175570 M0003647
Unique identifier applied to a drug concept within the National Drug File Reference Terminology (NDF-RT).
UNII:	Q40Q9N063P 5L51B4DR1G 73Y7P0K73Y XF417D3PSL PQ6CK8PD0R L7A49804ZQ 4G174V5051 1MBW07J51Q 0UV74P3R0J K848JZ4886 Load more... YKH834O4BH 88XHZ13131 VQ922CRY87 817L1N4CKP VZ3U1H7Q5B 0U46U6E8UK 25X51I8RD4 8ID597Z82X 19F5HK2737 56X6LID5ZY 8E272251DI 68Y4CF58BV TLM2976OFR 6CA025Y4FG POD38AIF08 AB6MNQ6J6L 70FD1KFU70 M572600E5P
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.
Pharmacologic Class MOA:	Acidifying Activity [MoA] Calcium Chelating Activity [MoA] Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA]
Mechanism of action of the drug—molecular, subcellular, or cellular functional activity—of the drug’s established pharmacologic class. Takes the form of the mechanism of action, followed by `[MoA]` (such as `Calcium Channel Antagonists [MoA]` or `Tumor Necrosis Factor Receptor Blocking Activity [MoA]`.
Pharmacologic Class EPC:	Calculi Dissolution Agent [EPC] Anti-coagulant [EPC] Vitamin C [EPC] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC] Catecholamine [EPC]
Established pharmacologic class associated with an approved indication of an active moiety (generic drug) that the FDA has determined to be scientifically valid and clinically meaningful. Takes the form of the pharmacologic class, followed by `[EPC]` (such as `Thiazide Diuretic [EPC]` or `Tumor Necrosis Factor Blocker [EPC]`.
Pharmacologic Class PE:	Decreased Coagulation Factor Activity [PE]
Physiologic effect or pharmacodynamic effect—tissue, organ, or organ system level functional activity—of the drug’s established pharmacologic class. Takes the form of the effect, followed by `[PE]` (such as `Increased Diuresis [PE]` or `Decreased Cytokine Activity [PE]`.
Pharmacologic Class CS:	Ascorbic Acid [CS] Catecholamines [CS]
Chemical structure classification of the drug product’s pharmacologic class. Takes the form of the classification, followed by `[Chemical/Ingredient]` (such as `Thiazides [Chemical/Ingredient]` or `Antibodies, Monoclonal [Chemical/Ingredient].
Pharmacologic Class:	Acidifying Activity [MoA] Adrenergic alpha-Agonists [MoA] Adrenergic beta-Agonists [MoA] Analogs/Derivatives [Chemical/Ingredient] Anti-coagulant [EPC] Ascorbic Acid [CS] Calcium Chelating Activity [MoA] Calculi Dissolution Agent [EPC] Catecholamine [EPC] Catecholamines [CS] Decreased Coagulation Factor Activity [PE] Magnetic Resonance Contrast Activity [MoA] Paramagnetic Contrast Agent [EPC] Vitamin B 6 [Chemical/Ingredient] Vitamin B6 Analog [EPC] Vitamin C [EPC] alpha-Adrenergic Agonist [EPC] beta-Adrenergic Agonist [EPC]
These are the reported pharmacological class categories corresponding to the SubstanceNames listed above.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
43742-1661-1	30 mL in 1 BOTTLE, DROPPER (43742-1661-1)	08 Jun, 2020	15 Oct, 2026	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Bio Co-enzyme Phase

Beta Vulgaris & more..

Liquid
Deseret Biologicals, Inc.
NDC: 43742-1661

Purpose:

Homeopathic indications: for the temporary relief of exhaustion, fatigue, and feelings of low energy.** **these statements are based upon homeopathic principles. they have not been reviewed by the food and drug administration.

Product Elements:

Bio co-enzyme phase beta vulgaris, ascorbicum acidum, cysteinum, natrum oxalaceticum, nicotinamidum, pulsatilla (pratensis), pyridoxinum hydrochloricum, riboflavinum, thiaminum hydrochloricum, alpha-ketoglutaricum acidum, alpha-lipoicum acidum, cerium oxalicum, citricum acidum, fumaricum acidum, magnesium oroticum dihydricum, malicum acidum, nadidum, natrum pyruvicum, pantothenic acid, succinicum acidum, adrenalinum, adenosinum triphosphoricum dinatrum, hepar sulphuris calcareum, sulphur, aconiticum acidum, cis-, beta vulgaris whole beta vulgaris whole ascorbic acid ascorbic acid cysteine cysteine sodium diethyl oxalacetate diethyl oxalacetate niacinamide niacinamide pulsatilla pratensis whole pulsatilla pratensis whole pyridoxine hydrochloride pyridoxine riboflavin riboflavin thiamine hydrochloride thiamine ion oxogluric acid .alpha.-ketoglutaric acid alpha lipoic acid .alpha.-lipoic acid cerous oxalate nonahydrate cerous cation anhydrous citric acid anhydrous citric acid fumaric acid fumaric acid magnesium orotate dihydrate orotic acid malic acid malic acid nadide nadide sodium pyruvate pyruvic acid pantothenic acid pantothenic acid succinic acid succinic acid epinephrine epinephrine adenosine triphosphate disodium adenosine triphosphate calcium sulfide calcium sulfide sulfur sulfur acetic acid acetic acid manganese phosphate, dibasic manganese cation (2+) proteus morganii proteus morganii barium oxalosuccinate barium cation water alcohol

Indications and Usage:

Warnings:

Warnings: keep out of reach of children. in case of overdose, contact a physician or poison control center right away. if pregnant or breast-feeding, ask a health professional before use. tamper seal: "sealed for your protection." do not use if seal is broken or missing.

Dosage and Administration:

Directions: 1-10 drops under the tongue, 2 times a day or as directed by a health professional. consult a physician for use in children under 12 years of age.

Package Label Principal Display Panel:

Package label display: des bio ndc 43742-1661-1 homeopathic bio co-enzyme phase 1 fl oz (30 ml) bio co-enzyme phase

Further Questions:

Questions: dist. by: deseret biologicals, inc. 469 w. parkland drive sandy, ut 84070 www.desbio.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.